Best in Biotech 26 Mar 2024
9 biotech companies leading the way in Denmark
…particle (VLP)-based vaccine, which is in phase 3 clinical development for active immunization against Chikungunya disease. The other candidate is a multi-valent vaccine candidate developed under contracts with the U.S….
